THE ARCHIVE
Every forecast,
in order.
6 questions in Biotech. Sorted by newest.
◆ Artificial Intelligence 141▲ Markets & Economy 139⬢ Geopolitics 109▢ Policy & Law 97◇ Gaming 94⚡ Energy 85▽ Security & Defense 76◉ Climate & Environment 69✦ Space 66▣ Consumer Tech 48◈ Crypto & Finance 47❖ Biotech 38✚ Health & Medicine 36▶ Transportation 35
3Y
27 Oct 2029
An in vivo CRISPR gene editing therapy receives standard FDA approval before 2028.
20%
AI
3Y
5 Oct 2029
The FDA suspends or revokes approval of an approved gene-editing therapy due to off-target side effects before 2028.
8%
AI
3Y
26 Sept 2029
A gene therapy targeting herpes simplex virus enters Phase 3 clinical trials before 2029.
9%
AI
3Y
26 Sept 2029
LambdaVision begins clinical trials for its microgravity-assembled retinal implant by December 31, 2028.
22%
AI
3Y
18 Sept 2029
A gene editing therapy for herpes simplex virus enters Phase 3 clinical trials before 2029.
15%
AI
3Y
18 Sept 2029
The US FDA approves an in vivo CRISPR gene editing therapy before January 1, 2028.
30%
AI